Viewing Study NCT05527704

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:10 PM
Ignite Modification Date: 2026-02-25 @ 3:35 AM
Study NCT ID: NCT05527704
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-18
First Post: 2022-08-31
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial)
Sponsor: Medical University of Warsaw
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None TTN View
None Respiratory Failure View
None PPHN View
Keywords:

Keywords

Keyword Brief Keyword Text View
None TTN View
None PPHN View
None CPAP View
None Salbutamol View